1-3 of 3
Daniel Geraghty, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

TET2 Mutations Are Associated with Poor Outcome in Pediatric AML: A Report From the Children's Oncology Group

Matthew A. Kutny, MD, Todd A. Alonzo, PhD, Robert B. Gerbing, MA, Daniel Geraghty, PhD, Alan S. Gamis, MD, MPH, Beverly Lange, MD, Nyla A. Heerema, PhD, Janet Franklin, MD, MPH, Susana C. Raimondi, PhD, Betsy A. Hirsch, PhD, Soheil Meshinchi, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 569.
https://doi.org/10.1182/blood.V118.21.569.569
Published: 2011
Journal Articles

TET2 SNP rs2454206 (I1762V) Correlates with Improved Survival In Pediatric Acute Myelogenous Leukemia, a Report From the Children's Oncology Group

Matthew A. Kutny, MD, Todd A. Alonzo, PhD, Robert B. Gerbing, MA, Phoenix A. Ho, MD, Daniel Geraghty, PhD, Beverly Lange, MD, Nyla A. Heerema, Ph.D., Soheil Meshinchi, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 949.
https://doi.org/10.1182/blood.V116.21.949.949
Published: 2010
Journal Articles

Activating KIR (B Haplotype) in Unrelated Donors Improves Disease-Free Survival after HLA-Matched and Mismatched Allogeneic Transplantation for Acute Myeloid Leukemia: Implications for Donor Selection Using KIR Genotyping.

Sarah Cooley, MD, Jeffrey S. Miller, MD, Elizabeth Trachtenberg, PhD, Tracy Bergemann, PhD, Koy Saeteurn, John Klein, PhD, Lisbeth A. Guethlein, Steven G.E. Marsh, PhD, Daniel Geraghty, PhD, Peter Parham, PhD, Daniel Weisdorf, MD
Journal: Blood
Blood (2007) 110 (11): 43.
https://doi.org/10.1182/blood.V110.11.43.43
Published: 2007